CDX Insider Trading

Insider Ownership Percentage: 34.98%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

CardieX Insider Trading History Chart

This chart shows the insider buying and selling history at CardieX by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CardieX Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 10/27/2021 12:11 PM ET

This chart shows the closing price history over time for CDX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

CardieX Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/25/2021Craig CooperInsiderBuy20,000,000A$0.05A$1,000,000.00
See Full Table

SEC Filings (Institutional Ownership Changes) for CardieX (ASX:CDX)

6.04% of CardieX stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

CardieX Limited designs, manufactures, and markets medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that measures arterial health by collecting digital vascular biomarkers using novel sensors. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables for home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.
Read More on CardieX

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

4.18%

Beta

1.6